Lexeo Therapeutics Inc. C... (LXEO)
NASDAQ: LXEO
· Real-Time Price · USD
4.71
-0.08 (-1.67%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.21%
After-hours: Aug 15, 2025, 05:36 PM EDT
Lexeo Therapeutics Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 28.91M | 35.01M | 157.02M | 174.98M | 195.06M | 121.47M | 35.45M | 45.54M | 58.85M | 77.33M |
Short-Term Investments | 70.92M | 86.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 7.04M | 7.01M | n/a | 3.25M | 3.25M | n/a | n/a | n/a | 3.26M | n/a |
Other Long-Term Assets | 3.25M | 3.25M | 3.25M | n/a | n/a | 3.25M | 3.25M | 3.25M | n/a | 3.25M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.44M | 4.6M | 2.44M | 2.17M | 3.03M | 3K | 2.01M | 1.24M | 2.37M | 371K |
Total Current Assets | 105.27M | 126.12M | 159.46M | 177.15M | 198.09M | 124.29M | 38.87M | 48.71M | 61.22M | 80.05M |
Property-Plant & Equipment | 10.13M | 10.56M | 11.15M | 11.61M | 11.86M | 12.26M | 12.6M | 12.97M | 13.34M | 13.78M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 20.42M | 20.82M | 14.41M | 14.86M | 15.12M | 15.51M | 15.85M | 16.23M | 16.6M | 17.03M |
Total Assets | 125.69M | 146.94M | 173.87M | 192.01M | 213.21M | 139.81M | 54.72M | 64.94M | 77.82M | 97.08M |
Account Payables | 11.98M | 6.42M | 8.44M | 5.76M | 4.3M | 3.79M | 2.65M | 2.37M | 3.91M | 2.68M |
Deferred Revenue | n/a | n/a | n/a | -10.99M | -2.61M | n/a | n/a | n/a | 448.7K | n/a |
Short-Term Debt | n/a | n/a | n/a | 2.67M | 2.61M | 2.6M | 4.15M | n/a | 2.75M | n/a |
Other Current Liabilities | 1.7M | 4.66M | 15.7M | -586K | -1.49M | 602K | 2M | 2.4M | 6.58M | 2.15M |
Total Current Liabilities | 30.82M | 22.85M | 26.82M | 18.88M | 21.63M | 17.24M | 23.04M | 13.66M | 13.69M | 14.35M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 185.03M | 185.03M | n/a | 185.03M |
Total Long-Term Liabilities | 6.75M | 7.25M | 7.72M | 8.18M | 8.63M | 9.03M | 194.5M | 194.9M | 10.28M | 195.68M |
Total Liabilities | 37.58M | 30.1M | 34.54M | 27.06M | 30.25M | 26.27M | 217.53M | 208.56M | 23.97M | 210.03M |
Total Debt | 9.4M | 9.92M | 10.4M | 10.85M | 11.24M | 11.64M | 16.21M | 12.66M | 13.03M | 13.48M |
Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | n/a | 2K | 1.71K | n/a |
Retained Earnings | -312.83M | -280.17M | -254.25M | -224.76M | -203.52M | -181.84M | -167.65M | -147.54M | -134.1M | -115.45M |
Comprehensive Income | -54K | -103K | n/a | n/a | n/a | n/a | n/a | -185.03M | -1.71K | n/a |
Shareholders Equity | 88.11M | 116.84M | 139.33M | 164.95M | 182.95M | 113.53M | -162.81M | -143.62M | 53.85M | -112.95M |
Total Investments | 77.95M | 93.52M | n/a | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.26M | n/a |